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Abstract
Background: Welding-associated air pollutants negatively affect the health of exposed workers; however, their molecular
mechanisms in causing disease remain largely unclear. Few studies have systematically investigated the systemic toxic
effects of welding fumes on humans.
Objectives: To explore the effects of welding fumes on the plasma metabolome, and to identify biomarkers for risk
assessment of welding fume exposure.
Methods: The two-stage, self-controlled exploratory study included 11 boilermakers from a 2011 discovery panel and 8
boilermakers from a 2012 validation panel. Plasma samples were collected pre- and post-welding fume exposure and
analyzed by chromatography/mass spectrometry.
Results: Eicosapentaenoic or docosapentaenoic acid metabolic changes post-welding were significantly associated with
particulate (PM2.5) exposure (p,0.05). The combined analysis by linear mixed-effects model showed that exposure was
associated with a statistically significant decline in metabolite change of eicosapentaenoic acid [b^(95%
CI) =20.013(20.022,20.004); p= 0.005], docosapentaenoic acid n3 [b^(95% CI) =20.010(20.018,20.002); p= 0.017], and
docosapentaenoic acid n6 [b^(95% CI) =20.007(20.013,20.001); p= 0.021]. Pathway analysis identified an association of
the unsaturated fatty acid pathway with exposure (pStudy22011 = 0.025; pStudy22012 = 0.021; pCombined = 0.009). The functional
network built by these fatty acids and their interactive genes contained significant enrichment of genes associated with
various diseases, including neoplasms, cardiovascular diseases, and lipid metabolism disorders.
Conclusions: High-dose exposure of metal welding fumes decreases unsaturated fatty acids with an exposure-response
relationship. This alteration in fatty acids is a potential biological mediator and biomarker for exposure-related health
disorders.
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Introduction
The impact of welding-associated air pollutants on the health of
exposed workers remains a major concern in occupational
medicine and public health [1]. Exposure to fine particles
(PM2.5) in ambient air increases the risk for acute disorders [2–
5] and chronic diseases [6–10]. Ultra-fine and fine welding
particles often contain various metals as a result of combustion;
these include iron, nickel, sulfur, copper, vanadium, cadmium, and
their oxides [11–13]. Metal particles may induce diverse biological
effects, including activation of mitogen-activated protein kinase
[14], DNA damage and cell apoptosis [5,15,16], lipid peroxidation
[16,17], and alteration of gene expression [18]. Further, fine metal
particles inhaled into the respiratory tract translocate to blood
circulation, which ultimately deposits particles in other organs and
produces systemic toxic effects.
Recently, metabolomics has attracted increasing interest in the
field of toxicology because it is a fast and reproducible method that
directly reflects biological events [19,20]. Metabolomics uses a
non-targeted approach to obtain an accurate representation of the
metabolome, including small molecules involved in highly
complex biochemical networks; global changes in the metabolome
may relate to particular diseases or phenotypes [21,22]. The use of
peripheral fluids, such as plasma or urine, for metabolomic
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analysis makes it an attractive method for studying the toxic effects
of various exposures such as welding fumes. To date, however, few
studies have investigated the systemic toxic effects of welding
fumes on humans.
Taking advantage of our well-established occupational cohort of
male boilermaker (welder) construction workers, we performed an
exploratory metabolomics study using a two-stage, self-controlled
design to explore the systemic toxic effects of welding fumes
measured as metabolic changes. This study identified biological
biomarkers for health risk assessment of welding fume exposure.
Materials and Methods
Ethics Statement
The Institutional Review Board at the Harvard School of Public
Health approved the study protocol, and informed written consent
was obtained from each adult prior to participation.
Study Design and Population
Eleven non-smoking, non-diabetic boilermakers at an appren-
tice welding school (Union Local 29, Quincy, MA) were recruited
in 2011 to participate in a discovery study (Study-2011); five of the
same subjects from Study-2011 and three new subjects were
recruited in 2012 (Study-2012) for validation. All participants were
selected from the well-characterized occupational cohort of male
boilermaker construction workers in Eastern Massachusetts as
previously described [23]. The welding school consists of a large,
temperature-controlled room outfitted with ten workstations
where the welders receive instruction and perform welding,
cutting, and grinding techniques. Boilermakers primarily per-
formed shielded metal arc (stick) and gas metal arc welding (TIG),
using base metals of mild steel (manganese alloys) and stainless
steel (manganese, chromium, and nickel alloys) with electrodes
composed mainly of iron with variable amounts of manganese
(1,5%). The same breakfast and lunch including turkey, chicken,
ham sandwiches and vegetables was provided for each participant
during workshop to control the inter-subject variability.
Data Collection
Peripheral blood samples were collected before (pre) and
immediately after the ,5 h welding workshop (post) from all
subjects. Samples were inventoried and immediately stored at
280uC. Samples of personal, integrated, gravimetric particulate
matters with an aerodynamic diameter of #2.5 mm (PM2.5) were
collected over the duration of the welding workshop. A self-
administered questionnaire collected information on medical
history, medication use, demographics, and smoking history as
previously described [13].
Metabolite Profiling
Sample preparation. Frozen samples were sent to Metabo-
lon, Inc. (Durham, NC) and accessioned into the Metabolon
LIMS system by a unique identifier associated with the original
source only. Samples were prepared using the automated
MicroLab STARH system (Hamilton Company, Reno, NV).
Recovery standards were added prior to the first step in the
extraction process for quality control purposes. Sample prepara-
tion used a proprietary series of organic and aqueous extractions to
remove proteins while allowing maximum recovery of small
molecules. The resulting extract was divided into two fractions:
Table 1. Characteristics of the study population.a
Characteristic Study-2011 (n=11) Study-2012 (n=8)b
PM2.5 total exposure 74.2627.4 114.9659.7
Age (years)c 49.1610.2 46.1611.7
BMI (kg/m2) 26.562.9 28.163.7
Male 11 8
Race White 9 6
Black 1 0
Hispanic 1 2
Medical history 3 4
Diabetes 0 0
Asthma 0 1
High blood pressure 1 1
High cholesterol hyperlipidemia 2 2
Medication use 4 4
Simvastatin for high cholesterol 2 1
Omeprazole for acid reflux 1 1
Lisinopril for high blood pressure 0 1
Fexofenadine for allergy 1 1
Ibuprofen for headaches 1 0
Albuterol for asthma 0 1
Oxycodone for fractured back 0 1
aValues presented either as mean6SD or n;
bFive subjects participated in both studies;
cAt study entry.
doi:10.1371/journal.pone.0077413.t001
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one for analysis by liquid chromatography (LC), and one for
analysis by gas chromatography (GC). Samples were placed briefly
on a TurboVapH (Zymark, Westborough, MA) to remove organic
solvents, frozen, and dried under vacuum. Extracted samples were
split into equal parts for analysis by gas chromatography/mass
spectrometry (GC/MS) and liquid chromatography/mass spec-
trometry (LC/MS) platforms. Several technical replicate samples
were created from a homogeneous pool containing a small amount
of each sample.
Instrument variability control. Instrument variability was
determined by calculating the median relative standard deviation
(RSD) for internal standards added to each sample prior to mass
spectrometer injection (RSD=5%). Overall process variability was
determined by calculating the median RSD for all endogenous
Figure 1. Flowchart for single-compound analysis. Metabolite changes (post-welding workshop – pre-welding workshop) for 333 compounds
were analyzed by regression with PM2.5 total exposure in Study-2011 (A) and Study-2012 (B), and by linear mixed-effects model in the combined
dataset of both studies (C). The y-axis represents the coefficients of exposure in regression models. The x-axis represents the metabolites ordered by
the effects of exposure from discovery analysis. Thirty biochemical metabolic changes significantly associated with exposure (p,0.05) in Study-2011.
Three of the thirty changes were validated in Study-2012 (p,0.05) and remained significant in combined analysis: eicosapentaenoic acid (EPA) and
docosapentaenoic acids (DPAn3, DPAn6).
doi:10.1371/journal.pone.0077413.g001
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metabolites (i.e., non-instrument standards) present in pooled
technical replicates (RSD=14%). Both RSD values meet
Metabolon’s acceptance criteria.
Data extraction and quality assurance. Raw MS data files
were loaded into a relational database. Peaks were identified using
Metabolon’s proprietary peak integration software, and compo-
nent parts were stored in a separate and specifically designed
complex data structure.
Compound identification. Compounds were identified by
comparison to library entries of purified standards or recurrent
unknown entities. Identification of known chemical entities was
based on comparison to the over 1,000 commercially available,
purified standard compounds registered in LIMS for distribution
to both LC and GC platforms.
Normalization. For studies spanning multiple days, data
normalization was performed to correct variation resulting from
instrument inter-day tuning differences. Each compound was
Figure 2. Scatter plots of metabolic changes by exposure of EPA and DPA. Scatter plots illustrate the biochemical compounds that had a
metabolic change significantly associated with welding fume exposure: A1) eicosapentaenoic acid (EPA); A2) EPA after removal of a potential outlier
(subject ID: 358); B) docosapentaenoic acid n3 (DPAn3); and C) docosapentaenoic acid n6 (DPAn6). The x-axis represents total PM2.5 exposure during
the welding workshop, while the y-axis represents biochemical metabolic change (post-welding workshop – pre-welding workshop). Black circles
represent data from Study-2011; red triangles represent data from Study-2012. Each mark is labeled with the subject ID.
doi:10.1371/journal.pone.0077413.g002
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corrected in run-day blocks by equalizing the medians to 1.00 and
normalizing each data point proportionately. Normalized metab-
olites were used for analysis.
Statistical Analysis
Demographics were presented by frequencies for categorical
variables and means 6 standard deviation (mean 6 SD) for
continuous variables. The change of each metabolite during
welding day (D=post-pre) was calculated for each subject. The
permutation test with 10,000 perturbations was used to test global
metabolic changes between post- and pre-welding workshop
samples.
To investigate the association between metabolic change and
PM2.5 exposure, univariate linear regression was used in Study-
2011 (Eq. 1). Compounds with p#0.05 were further validated in
Study-2012 using the same statistical model, followed by combined
analysis of both studies using linear mixed-effects model (LMM)
given a random slope of exposure for each study and
autoregressive correlation structure (Eq. 2). The multiple compar-
ison was adjusted by false discovery rate (FDR) [24]
Di~b:PM2:5total exposureizei ð1Þ
where i=1, …, 11 in Study-2011 and i=1, …, 8 in Study-2012.
Dij~azb1j
:PM2:5total exposureij
zb2
:ageijzb3
:medication useijzeij
ð2Þ
where i~1, …, 14 to represent each subject; j~1or 2 to denote
each study (1 = Study-2011; 2= Study-2012).
For pathway-level association analysis, principal component
analysis (PCA) was performed to generate the first principal
component (PC1) from all metabolites of each pathway. PC1 was
used as the response to perform linear regression with exposure in
Study-2011 and Study-2012 separately, and perform LMM for
combined analysis with adjustment for age and medication use.
LMM analysis was performed by R ‘‘nlme’’ package. All statistical
analyses were performed using R Version 15.0 (http://cran.r-
project.org).
The functional network was built using MetaCoreTM online
software (GeneGo Inc., Carlsbad, CA) to illustrate potential
biological connections of significant compounds and interactive
genes. Enrichment analysis for disease-associated genes was
conducted for each network in MetaCoreTM. The p value for
enrichment analysis was calculated using Eq. 3:
p~
R!n!(N{R)!(N{n)!
N!
Xmin (n,R)
i~max (r,Rzn{N)
1
i!(R{i)!(N{R{nzi)!
ð3Þ
where N denotes the total number of genes that were causally
associated with all diseases and disorders in MetaCoreTM; n
denotes the total number of genes that were causally associated
with the intersecting disease of interest (e.g., lipid metabolism
disorders); R denotes the total number of genes/proteins visible in
the network; and r denotes the total number of genes/proteins
visible in the network intersecting with the disease of interest.
Table 2. Metabolites associated with PM2.5 metal welding fume exposure.
Baseline D (post - pre)
Metabolite Study-2011 Study-2012 Study-2011 Study-2012
Eicosapentaenoate (EPA; 20:5n3) 1.0660.44(0.45,1.89) 1.4260.67(0.70,2.88) 20.0660.58(21.08,0.78) 0.0661.28(20.86,3.15)
Docosapentaenoate (DPAn3; 22:5n3) 1.2960.71(0.45,2.68) 1.0960.29(0.65,1.48) 20.3160.98(21.83,1.01) 20.1560.56(21.07,0.87)
Docosapentaenoate (DPAn6; 22:5n6) 1.3260.60(0.52,2.4) 1.1060.33(0.70,1.67) 20.3060.75(21.83,0.74) 20.3560.49(21.31,0.22)
*Values presented as mean 6 SD (min,max).
doi:10.1371/journal.pone.0077413.t002
Table 3. Association of PM2.5 metal welding fume exposure with metabolite change.
Association analysis a Combined analysis a,b
Study-2011 Study-2012 Univariate analysis Multivariate analysis
Metabolite b(95% CI) p b(95% CI) p b(95% CI) p qc b(95% CI) p qc
Eicosapentaenoate (EPA; 20:5n3) 20.013(20.026,
20.001)
0.038 20.014(20.027,
20.001)
0.033 20.013(20.022,
20.004)
0.005 0.249 20.014(20.023,
20.006)
0.003 0.229
Docosapentaenoate (DPAn3; 22:5n3) 20.025(20.044,
20.005)
0.018 20.007(20.013,
20.002)
0.017 20.010(20.018,
20.002)
0.017 0.313 20.010(20.019,
20.001)
0.020 0.398
Docosapentaenoate (DPAn6; 22:5n6) 20.016(20.032,
20.0002)
0.048 20.006(20.012,
20.0005)
0.038 20.007(20.013,
20.001)
0.021 0.313 20.021(20.013,
20.001)
0.029 0.418
aTotal PM2.5 exposure as predictor, metabolite change as response;
bLinear mixed-effects model was used with/without adjustment for age and medication use;
cq represented FDR adjusted p value using Benjamini & Hochberg method.
doi:10.1371/journal.pone.0077413.t003
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Results
Study-2011 consisted of eleven male boilermakers with a mean
age of 49.1610.2 years, average body mass index (BMI) of
26.562.9, and of whom 82% were white (Table 1). Three
participants reported medical history, two with hyperlipidemia
and one with hypertension; four participants reported medication
use for high cholesterol, seasonal allergy, asthma, etc. Eight
boilermakers were recruited in Study-2012 for validation; the
characteristics of this cohort did not significantly differ from Study-
2011 (Table 1). No participants reported metal fever during
welding workshop.
Single Biochemical Analysis
Plasma samples were collected from each participant prior to
and after a welding workshop for metabolomic profiling. We
identified 333 compounds of known biochemical identity that
comprised the analysis dataset. In Study-2011, 30 of 333 detected
compounds were significantly associated with a metabolic change
during welding workshop (D) with total PM2.5 exposure (p#0.05);
Table 4. Association of PM2.5 metal welding fume exposure with metabolite pathways.
Study-2011d Study-2012d Combined analysisf
Pathway Na N2
b N3
c VPC1
e p VPC1
e p VPC1
e p padj
Unsaturated fatty acid 7 7 6 0.84 0.025 0.81 0.021 0.77 0.009 0.013
Phenylalanine & tyrosine metabolism 13 8 1 0.29 0.013 0.36 0.547 0.24 0.425 0.480
aNumber of biochemical compounds within the same pathway;
bNumber of biochemical compounds that have the same coefficient direction when regressed by exposure both in Study-2011 and Study-2012;
cNumber of biochemical compounds with association p,0.05 in combined dataset analyzed by linear mixed model with adjustment of age and medication use;
dFirst principal component (PC1) was used as response, with PM2.5 total exposure as predictor in linear regression model or linear mixed-effects model;
eProportion of variance explained by PC1;
fPC1 was used as response in the linear mixed model with random slope with or without adjustment of age and medication use.
doi:10.1371/journal.pone.0077413.t004
Figure 3. Functional network for EPA and DPA. Network analysis revealed that intracellular and extracellular eicosapentaenoic acid (EPA)
interact with 19 genes, while docosapentaenoic acid (DPA) interacts with 7 genes; EPA, DPAn3, DPAn6, and 24 regulated genes were used to build the
illustrated functional network. The green line represents activation; the red line represents inhibition; the gray line represents unspecified effects.
doi:10.1371/journal.pone.0077413.g003
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however, only three passed validation in Study-2012 by the criteria
of consistent effect direction of exposure and p#0.05 (Figure 1,
Table 2). The combined LMM analysis showed that total PM2.5
exposure associated with a statistically significant (p,0.05) decline
in metabolic change of eicosapentaenoic acid (EPA) (b^=20.013/
mg/m3; 95% CI=20.022,20.004; p=0.005; q=0.249), doc-
osapentaenoic acid n3 (DPAn3) (b^=20.010/ mg/m3; 95%
CI=20.018,20.002; p=0.017; q=0.313), and docosapentae-
noic acid n6 (DPAn6) (b^=20.007/ mg/m3; 95%
CI=20.013,20.001; p=0.021; q=0.313) (Figure 2). Adjust-
ment for age and medication use did not affect significance
(Table 3). LMM application with random intercepts for each study
provided consistent results; however, the model did not reach
convergence when random intercept and random slope were
simultaneously considered.
In Study-2012, one subject (ID: 358) exhibited EPA metabolic
changes much larger than others. These data were therefore
removed for subsequent sensitivity analysis, which displayed a
consistent trend while losing statistical significance (p=0.447); the
combined analysis remained statistically significant in univariate
analysis (p=0.030) and multivariate analysis (p=0.041) (Figure 2-
A2).
The five subjects who participated in both studies were also
separately assessed by sensitivity analysis using an LMM with
random slopes for each subject. Borderline statistical significance
remained for EPA (pStudy-2011 = 0.070; pStudy-2012 = 0.088; pCom-
bined = 0.042; pCombined = 0.012 with adjustment for age and
medication use) and DPAn3 (pStudy-2011 = 0.041; pStudy-
2012 = 0.031; pCombined = 0.003; pCombined = 0.066 with adjustment
for age and medication use). LMM with random intercepts for
each subject yielded similar results.
Conversely, sensitivity analysis was performed excluding the five
subjects from Study-2011 who participated in both studies; this
analysis included six subjects for Study-2011 and eight subjects for
Study-2012. Combined analysis remained significant or borderline
significant for EPA (p=0.046), DPAn3 (p=0.064), and DPAn6
(p=0.020), even after adjustment for age and medication use.
Pathway Analysis
EPA, DPAn3, and DPAn6 participate in the biosynthesis of
unsaturated fatty acids (KEGG entry: map01040). To explore
whether this pathway connects metabolites associated with PM2.5
metal fume exposure, we performed PCA to integrate multiple
biochemicals within each pathway. While two of 63 pathways
significantly associated with PM exposure (p#0.05) in Study-2011,
only the unsaturated fatty acids pathway was replicated in Study-
2012 (pStudy-2011 = 0.025; pStudy-2012 = 0.021) and appeared in the
combined analysis (p=0.009, q=0.145; padj = 0.013, q=0.204)
(Table 4). Seven biochemical molecules were detected in the
unsaturated fatty acids pathway for which metabolic change
negatively associated with exposure dosage; six of the seven
molecules were statistically significant by combined analysis of
both studies (Table S1).
Functional Network Analysis
To explore interactions of EPA and DPA with specific genes, we
performed a functional network analysis. EPA extracellular and
intracellular metabolites interacted with 19 genes; DPA interacted
with 7 genes. All metabolite compounds and 24 interactive genes
were then used to build a network (Figure 3). Using a priori
knowledge, the top five diseases that associated with the most
interactive genes within the network (21/24 genes) were endocrine
system diseases (p=1.6610260), neoplasms (p=2.0610259), lung
disease (p=2.0610259), respiratory tract diseases (p=2.0610259),
and digestive system diseases (p=2.0610259). Additionally, 16 of
24 genes associated with cardiovascular disease (p=1.3610241),
and 9 of 24 genes associated with lipid metabolism disorders/
hyperlipidemias (p=2.2610227). These disease enrichment pro-
files remained significant when all seven compounds were used to
build a network by the same approach.
Discussion
A challenge to understand the adverse effects of welding fume
exposure is the complex nature of environmental and behavioral
influences. Metabolic profiles are greatly affected by diet, smoking
behavior, medical history, or even time [25–29]. Kuo et al.
recruited non-smoking, non-alcohol drinking welders for a
metabolomic study, but intra-subject variation was not considered
[30]. Here, we excluded smoking or diabetic boilermakers to
reduce such confounding effects. A self-controlled design elimi-
nated intra-subject variation, and a two-stage design avoided
chance findings in our limited sample size.
The main finding of this study is that unsaturated fatty acids are
consistently reduced by respirable welding fume exposure, with a
significant negative exposure-response relationship. To date, many
studies have investigated the beneficial effects of EPA and DHA in
neural function [31], tumor suppression [32], cardiovascular event
risk reduction [33], diabetes mellitus [34,35], anti-inflammatory
activity [36], and blood lipid reduction [37]. Although the roles of
DPA have not yet been systematically examined because of the
lack of available pure DPA, there is some evidence that DPA has
stronger beneficial health effects than EPA and DHA in vitro [38].
We also detected a global metabolite change, which may be
explained by diet during work shift, circadian variation [30], or
PM2.5 exposure.
Surprisingly, the functional network built from unsaturated fatty
acids includes 24 genes that showed very intense biological
functions related to various diseases, including those involving
endocrine system diseases, respiratory diseases, neoplasms, car-
diovascular diseases, and lipid metabolism disorders. Intracellular
EPA activates peroxisome proliferator-activated receptors (PPARs)
[39], which are implicated in the pathology of numerous diseases
including obesity, diabetes, atherosclerosis, and cancer (RefSeq,
Jul 2008). EPA also inhibits COX-1/COX-2 [40], which encode
proteins that may promote cell proliferation during tumor
progression (RefSeq, Sep 2012). DPA activates RXRG [41], a
member of the retinoid X receptor family that is involved in
mediating the anti-proliferative effects of retinoic acid and is
down-regulated in several types of human cancers, including lung
cancer [42]; DPA also activates cysteine-aspartic acid protease
(Caspase) family members, which are involved in cancer cell
apoptosis [43]. The functional network analysis strengthens the
hypothesis that the decline of unsaturated fatty acids is a potential
mediator of multiple health disorders in boilermakers.
Previous studies demonstrate the association of welding fume
exposure on decline of heart rate variability (HRV), an important
indicator of cardiovascular disease morbidity [4,44,45]. Interest-
ingly, several recent studies show that supplementation of EPA
and DPA benefit HRV in healthy adults, cardiovascular disease
risk populations, or in cardiovascular disease patients [46–50].
These results strongly indicate that the metabolic change of
unsaturated fatty acids is an important biological mediator of
exposure-related decreases in HRV.
Despite these findings, we recognize limitations to the study: we
lack metabolite information from a non-welding day, and p values
were not small enough to pass multiple comparison correction due
Metal Fume Exposure and Unsaturated Fatty Acids
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to small sample size. However, pathway-based analysis showed an
acceptable FDR (q,0.2), and the two-stage, self-controlled study
design helped reduce chance findings.
In summary, this exploratory study shows evidence that high
dose exposure of metal welding fumes decreases unsaturated fatty
acids with an exposure-response relationship. The metabolic
change in unsaturated fatty acids is a potential biomarker for
exposure-related health disorders for which further studies are
encouraged.
Supporting Information
Table S1 Association analysis for metal welding fume exposure
and metabolic change of biochemical compounds of unsaturated
fatty acid pathway.
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